The proliferative potential of myeloma plasma cells manifest in the SCID-hu host

Blood

Volumn 94, Issue 10, 1999, Pages 3576-3582

  Yaccoby, Shmuel ^a   Epstein, Joshua ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; MOUSE; MYELOMA; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; STEM CELL;

EID: 0033570946     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.10.3576.422k01_3576_3582     Document Type: Article

References (28)

1. Kubagawa H, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper MD: Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med 150:792, 1979
2. Mellstedt H, Hammarstrom S, Holm G: Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol 17:371, 1974
3. Pilarski LM, Andrews EJ, Serra HM, Ledbetter JA, Ruether BA, Mant MJ: Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Am J Hematol 30:53, 1989
4. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM: Circulating monoclonal B cells in myeloma adhere to bone marrow (BM) fibroblasts and have motile behavior but BM plasma cells are sessile. Blood 84:171a, 1994 (abstr, suppl 1)
5. Epstein J: Myeloma phenotype: Clues to disease origin and manifestation [Review]. Hematol Oncol Clin North Am 6:249, 1992
6. Epstein J: Myeloma stem cell phenotype. Implications for treatment [Review]. Hematol Oncol Clin North Am 11:43, 1997
7. Epstein J, Barlogie B, Katzmann J, Alexanian R: Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood 71:861, 1988
8. Corradini P, Boccadoro M, Voena C, Pileri A: Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)-and IgA-secreting multiple myelomas. J Exp Med 178:1091, 1993
9. Corradini P, Voena C, Omede P, Astolfi M, Boccadoro M, Dalla-Favera R, Pileri A: Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia 7:1879, 1993
10. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
11. Billadeau D, Greipp P, Ahmann G, Witzig T, Van Ness B: Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS. Curr Top Microbiol Immunol 194:9, 1995
12. Kay NE, Leong T, Kyle RA, Greipp P, Billadeau D, Van Ness B, Bone N, Oken MM: Circulating blood B cells in multiple myeloma: Analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial. Blood 90:340, 1997
13. Chen BJ, Epstein J: Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood 87:1972, 1996
14. Bergui L, Schena M, Gaidano G, Riva M, Caligaris-Cappio F: Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma. J Exp Med 170:613, 1989
15. Caligaris-Cappio F, Bergui L, Tesio L, Pizzolo G, Malavasi F, Chilosi M, Campana D, Van Camp B, Janossy G: Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest 76:1243, 1985
16. Thomas X, Xiao HQ, Chang R, Epstein J: Circulating B lymphocytes in multiple myeloma patients contain an autocrine IL-6 driven pre-myeloma cell population. Curr Top Microbiol Immunol 182:201, 1992
17. Pilarski LM, Belch AR: Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 83:724, 1994
18. Pilarski LM, Cass CE, Tsuro T, Belch AR: Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma. Curr Top Microbiol Immunol 182:177, 1992
19. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988
20. Namikawa R, Ueda R, Kyoizumi S: Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice. Blood 82:2526, 1993
21. Yaccoby S, Barlogie B, Epstein J: Primary myeloma cells growing in SCID-hu mice - A model for studying the biology and treatment of myeloma and its manifestations. Blood 92:2908, 1998
22. Hata H, Xiao H, Petrucci MT, Woodliff J, Chang R, Epstein J: Interleukin-6 gene expression in multiple myeloma: A characteristic of immature tumor cells. Blood 81:3357, 1993
23. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B: Analysis of B-lymphoid malignancies using allelespecific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78:3021, 1991
24. Lokhorst HM, Boom SE, Bast BJ, Ballieux RE: Determination of the plasma cell labeling index with bromodeoxyuridine in a double fluorescence technique. Br J Haematol 64:271, 1986
25. Pringle JH, Primrose L, Kind CN, Talbot IC, Lauder I: In situ hybridization demonstration of poly-adenylated RNA sequences in formalin-fixed paraffin sections using a biotinylated oligonucleotide poly d(T) probe. J Pathol 158:279, 1989
26. Brown R, Luo XF, Gibson J, Morley A, Sykes P, Brisco M, Joshua D: Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization. Br J Haematol 90:113, 1995
27. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
28. Witzig TE, Dhodapkar MV, Kyle RA, Greipp PR: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993